Shots double risk of acute coronary syndrome

Researchers have also found Pfizer and Moderna mRNA COVID-19 shots dramatically increase biomarkers associated with thrombosis, cardiomyopathy, and other vascular events following injection.

People who had received two doses of the mRNA jab more than doubled their five-year risk of an acute coronary syndrome (ACS), the researchers found, driving it from an average of 11% to 25%.

ACS is an umbrella term that includes not only heart attacks but also a range of other conditions involving abruptly reduced blood flow to your heart. In a Nov. 21, 2021 tweet, cardiologist Dr. Aseem Malhotra wrote:

“Extraordinary, disturbing, upsetting. We now have evidence of a plausible biological mechanism of how mRNA vaccine may be contributing to increased cardiac events. The abstract is published in the highest impact cardiology journal so we must take these findings very seriously.”

AMA is A-OK with sacrificing children

Tragically, it’s not only the CDC and FDA that have been captured by the drug industry and who are sacrificing public health, including the health of our children, in order to further the technocratic Great Reset agenda.

Even the American Medical Association, which is supposed to lobby for physicians and medical students in the U.S. and promote a medicine for the betterment of public health, has abandoned all semblance of ethics, transparency, and honesty.

In a mid-November 2021 article on the AMA’s website, “COVID-19 Vaccine for Kids: How We Know It’s Safe,” contributing news writer Tanya Albert Henry cites data straight from Pfizer’s press release and then goes on to claim we “know it’s safe” because “younger children see the same side effects as has been seen in adults and teens.”

Based on the VAERS data, that should send shivers down parents’ backs.

“The American Academy of Pediatrics is on board with vaccinating this age group, along with the American Academy of Family Physicians and the Pediatrics Infectious Diseases Society, said Dr. Fryhofer, chair-elect the AMA Board of Trustees,” Henry writes.

“Dr. Fryhofer … noted that myocarditis has been a rare occurrence after the second dose of the mRNA vaccines. ‘The observed risk is highest in young males age 12 to 29, but COVID infection can also cause myocarditis,’ she pointed out. ‘For adolescents and young adults, the risk of myocarditis caused by COVID infection is much higher than after mRNA vaccination.’”

Really? Where did Fryhofer get that idea? I’ve not seen any data to back that up, and Henry doesn’t provide any.

What do the VAERS data show?

Research published in 2017 calculated the background rate of myocarditis in children and youth, showing it occurs at a rate of four cases per million per year.

According to the U.S. Census Bureau, as of 2020, there were 73.1 million people under the age of 18 in the U.S. That means the background rate for myocarditis in adolescents (18 and younger) would be about 292 cases per year.

As of Dec. 17, 2021, looking only at U.S. reports and excluding the international ones, VAERS had received:

  • 308 cases of myocarditis among 18-year-olds.
  • 252 cases among 17-year-olds.
  • 226 cases in 16-year-olds.
  • 256 cases in 15-year-olds.
  • 193 in 14-year-olds.
  • 132 in 13-year-olds.
  • 108 in 12-year-olds.

In total, that’s 1,475 cases of myocarditis in teens aged 18 and younger — five times the background rate. And again, this does not take into account the underreporting rate, which has been calculated to be anywhere from five to 40.

Meanwhile, the CDC claims that, between March 2020 and January 2021, “the risk for myocarditis was 0.146% among patients diagnosed with COVID-19,” compared to a background rate of 0.009% among patients who did not have a diagnosis of COVID-19.

After adjusting for “patient and hospital characteristics,” COVID-19 patients between the ages of 16 and 39 were on average seven times more likely to develop myocarditis than those without COVID.

That said, the CDC stressed that “Overall, myocarditis was uncommon” among all patients, COVID or not. What’s more, only 23.7% of myocarditis patients between the ages of 16 and 24 had a history of COVID-19, so a majority of the cases in that age group were not due to COVID.

We’re also not talking about big numbers in terms of actual COVID infections. The weekly adolescent hospitalization rate peaked at 2.1 per 100,000 in early January 2021, declined to 0.6 per 100,000 in mid-March, and rose to 1.3 per 100,000 in April.

Using that peak hospitalization rate of 2.1 per 100,000 (or 21 per million) in this age group, and assuming the risk for myocarditis is 0.146% among COVID-positive patients, we get a myocarditis-from-COVID rate among adolescents of 0.03 per million.

That’s a far cry from the normal background rate of four cases per million, so the risk of getting myocarditis from SARS-CoV-2 infection is probably quite small.

Now, assuming the COVID hospitalization rate for adolescents is 21 per million, and we have 73.1 million adolescents, we could expect there to be 1,535 hospitalizations for COVID in this age group in a year.

If 0.146% of those 1,535 teens develop myocarditis, we could expect 2.2 cases of myocarditis to occur in this age group each year, among those who come down with COVID.

In summary, based on CDC statistics, we could expect just over two teens to contract myocarditis from COVID-19 infection. Meanwhile, we have 1,475 cases reported following the COVID jab in just six months (shots for 12- to 17-year-olds were authorized July 30, 2021).

Taking into account underreporting, the real number could be anywhere between 7,375 and 59,000 — again, in just six months! To estimate an annual rate, we’d have to double it, giving us anywhere from 14,750 to 118,000 cases of myocarditis.

So, is it actually true that “For adolescents and young adults, the risk of myocarditis caused by COVID infection is much higher than after mRNA vaccination.”? I doubt it.

Originally published by Mercola.